Bioxcel Therapeutics Inc (NQ: BTAI )

1.370 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Jun 14, 2024 Add to My Watchlist

Price and Volume

Volume	5,064
Open	1.370
Bid (Size)	1.340 (83)
Ask (Size)	1.380 (82)
Prev. Close	1.370
Today's Range	1.370 - 1.370
52wk Range	1.320 - 20.16
Shares Outstanding	37,530,821
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

BTAI Stock Earnings: BioXcel Therapeutics Misses EPS, Beats Revenue for Q1 2024

May 09, 2024

BTAI stock results show that BioXcel Therapeutics missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

Via InvestorPlace

AI Surge Has Ended: All 7 AI Stock Categories Declined This Week

April 13, 2024

From no AI category losses in February, to 3 drops in March - now all 7 fell this week, clearly indicating that that the surge in AI stock prices that began back on October 31st is, indeed, over.

Via Talk Markets

Performance

YTD	-53.24%	-53.24%
1 Month	-33.82%	-33.82%
3 Month	-50.00%	-50.00%
6 Month	-57.05%	-57.05%
1 Year	-93.11%	-93.11%

More News

Six Of Seven AI Stock Categories Increased This Week

March 23, 2024

Via Talk Markets

BioXcel Therapeutics's Earnings Outlook

March 11, 2024

Via Benzinga

7 Short-Squeeze Stocks That Could Send the Bears Into Panic-Mode

March 07, 2024

Via InvestorPlace

Why BioXcel Therapeutics Shares Are Falling Today

February 09, 2024

Via Benzinga

Earnings Scheduled For March 12, 2024

March 12, 2024

Via Benzinga

AI-Powered Drug Discovery Stocks Index Up 9% In February; Remains Down 8% YTD

March 04, 2024

Via Talk Markets

12 Health Care Stocks Moving In Tuesday's After-Market Session

February 27, 2024

Via Benzinga

AI-Powered Drug Discovery Stocks Index Up 18% Last Week, Led By BioXcel Therapeutics

February 19, 2024

Via Talk Markets

12 Health Care Stocks Moving In Wednesday's Intraday Session

February 14, 2024

Via Benzinga

Leading The Charge: Tonix Pharmaceuticals And The Future Of CNS Therapeutics

February 13, 2024

Via Get News

Why BioXcel Therapeutics Shares Are Rising Tuesday

February 13, 2024

Via Benzinga

Anal Cancer Treatment Market Expected to Reach $1.63 Billion by 2030 as Latest Clinical Studies Focus on New Therapies

February 14, 2024

Via FinancialNewsMedia

12 Health Care Stocks Moving In Tuesday's Intraday Session

February 13, 2024

Via Benzinga

Anal Cancer Treatment Market Expected to Reach $1.63 Billion by 2030 as Latest Clinical Studies Focus on New Therapies

February 14, 2024

From FN Media Group LLC

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Pre-Market Session

February 12, 2024

Via Benzinga

BIOXCEL ALERT: Bragar Eagel & Squire, P.C. is Investigating BioXcel Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

February 09, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's After-Market Session

February 09, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session

February 09, 2024

Via Benzinga

Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session

February 09, 2024

Via Benzinga

Why Is CleanSpark (CLSK) Stock Up 27% Today?

February 09, 2024

Via InvestorPlace

S&P 500 Tops 5,000; PepsiCo Posts Upbeat Earnings

February 09, 2024

Via Benzinga

Why Is BioXcel Therapeutics (BTAI) Stock Down 26% Today?

February 09, 2024

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Pre-Market Session

February 09, 2024

Via Benzinga

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.